OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ATOS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Atossa Therapeutics (ATOS) Earnings Date & Reports

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

ATOS is expected to report earnings to fall 17.86% to -5 cents per share on November 17

Atossa Therapeutics ATOS Stock Earnings Reports

Q3'25

Est.

$-0.06

Q2'25

Missed

by $0.01

Q1'25

Beat

by $0.02

Q4'24

Beat

by $0.02

Q3'24

Est.

$-0.06

The last earnings report on August 12 showed earnings per share of -7 cents, missing the estimate of -5 cents. With 240.43K shares outstanding, the current market capitalization sits at 100.30M.

View a ticker or compare two or three

Compare

ATOS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ATOS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ATOS showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a manufacturer of products for breast cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Medical Specialties

Address

107 Spring Street

Phone

+1 206 588-0256

Employees

Web

https://www.atossatherapeutics.com